CARsgen Therapeutics Holdings Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
CARsgen Therapeutics Holdings has a total shareholder equity of CN¥1.5B and total debt of CN¥129.1M, which brings its debt-to-equity ratio to 8.6%. Its total assets and total liabilities are CN¥2.1B and CN¥605.2M respectively.
Belangrijke informatie
8.6%
Verhouding schuld/eigen vermogen
CN¥129.12m
Schuld
| Rente dekkingsratio | n/a |
| Contant | CN¥1.65b |
| Aandelen | CN¥1.50b |
| Totaal verplichtingen | CN¥605.18m |
| Totaal activa | CN¥2.10b |
Recente financiële gezondheidsupdates
Analyse van de financiële positie
Kortlopende schulden: 2171's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥183.7M).
Langlopende schulden: 2171's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥421.5M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 2171 has more cash than its total debt.
Schuld verminderen: Insufficient data to determine if 2171's debt to equity ratio has reduced over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: 2171 has sufficient cash runway for more than a year based on its current free cash flow.
Voorspelling contante baan: 2171 has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 9.1% each year.